The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages

Date: 10 October 2015

Introduction: Manuscript accepted for publication in Inflammation.

Waumans et al. have published their new findings on DPP4, 8 and 9 in a manuscript The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages: DPP8/9 Inhibition Attenuates M1 Macrophage Activation in Mice.

Abstract 
Atherosclerosis remains the leading cause of death in Western countries. Dipeptidyl peptidase (DPP) 4 has emerged as a novel target for the prevention and treatment of atherosclerosis. Family members DPP8 and 9 are abundantly present in macrophage-rich regions of atherosclerotic plaques, and DPP9 inhibition attenuates activation of human M1 macrophages in vitro. Studying this family in a mouse model for atherosclerosis would greatly advance our knowledge regarding their potential as therapeutic targets.

We found that DPP4 is downregulated during mouse monocyte-to-macrophage differentiation. DPP8 and 9 expression seems relatively low in mouse monocytes and macrophages. Viability of primary mouse macrophages is unaffected by DPP4 or DPP8/9 inhibition. Importantly, DPP8/9 inhibition attenuates macrophage activation as IL-6 secretion is significantly decreased. Mouse macrophages respond similarly to DPP inhibition, compared to human macrophages.

This shows that the mouse could become a valid model species for the study of DPPs as therapeutic targets in atherosclerosis.



Url: http://link.springer.com/article/10.1007%2Fs10753-015-0263-5